×
戻る Agenda
Session2:From Silos to Systems: Rethinking Talent for Regenerative Medicine Innovation
Session Chair(s)
Kenichiro Hata, MD, PHD
President and CEO,
Japan Tissue Engineering Co., Ltd., Japan
Keiji Miyamoto
Principal Post-Marketing Regulatory Affairs Dep.
Daiichi Sankyo Co.,Ltd., Japan
Speaker(s)
Masao Sasai, PHD
the University of Osaka, Japan
Department of Medical Innovation, Specially Appointed Assistant Professor
Kazunobu Oyama, PHD
Daiichi Sankyo Company, Limited, Japan
CMC Regulatory Affairs, Director
Naoki Hosen
The University of Osaka, Japan
Hematology, cancer immunology, Professer
Yoko Kobayashi
Pharmaceuticals and Medical Devices Agency, Japan
Yoshie Tsurumaki
HEALIOS K.K., Japan